Skip to main content
. 2023 Mar 16;29(11):2052–2065. doi: 10.1158/1078-0432.CCR-22-3642

Table 2.

Metastatic location and tumor biopsy site.

Best RECIST response (this clinical trial): Metastatic site # of patients Tumor biopsy site # of patients
PD Lymph node 4 Lymph node 3
Lung 5 Lung 4
Liver 3 Liver 4
Multiple locations 5 Primary 4
Other 2
SD confirmed Lymph node 4 Lymph node 2
Primary 2